🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Richard J. Santen

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 3 papers. Top paper: “Aromatase in breast cancer and the role of aminoglutethimide and other aromatase inhibitors”.

Aromatase in breast cancer and the role of aminoglutethimide and other aromatase inhibitors

Critical Reviews in Oncology/Hematology(1986)10.1016/s1040-8428(86)80003-8

N/A

3.7DataRank · unranked

46 citations

Richard J. Santen, I. Criag Henderson, Angela M.H. Brodie

Clinical use of aromatase inhibitors in human breast carcinoma

The Journal of Steroid Biochemistry and Molecular Biology(1991)10.1016/0960-0760(91)90189-c

N/A

2.6DataRank · unranked

32 citations

Richard J. Santen

Additive effects of aminoglutethimide testololactone, and 4-hydroxyandrostenedione as inhibitors of aromatase

Journal of Steroid Biochemistry(1984)10.1016/0022-4731(84)90151-1

N/A

1.4DataRank · unranked

21 citations

Howard Rosen, Yoshio Osawa, Richard J. Santen, Steven J. Santner